Age: Any Age
Sex: Any
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: N/A
Waitlist Available
Sponsor: Hutchison Medipharma Limited
No Placebo Group
Trial Summary
What is the purpose of this trial?This treatment protocol is intended to provide early access of surufatinib to patients with locally advanced or metastatic NETs for whom, in the opinion of their treating physician, other treatment options or surufatinib clinical trials in this indication are unsuitable. This EAP is currently available in the US only.
Eligibility Criteria
Treatment Details
Find a clinic near you
Research locations nearbySelect from list below to view details:
Intermountain Cancer CenterSaint George, UT
Roswell Park Cancer InstituteBuffalo, NY
Texas Oncology - Baylor Charles A. Sammons Cancer CenterDallas, TX
Avera Cancer InstituteSioux Falls, SD
More Trial Locations
Loading ...
Who is running the clinical trial?
Hutchison Medipharma LimitedLead Sponsor
HutchmedLead Sponsor